Volume 1 · Issue 2
Precision Neurology
Clinical research on diagnosis, classification and biomarkers across epilepsy, neuroimmunology, headache and disorders of the peripheral nervous system.
100 Creative Commons readings · Paulina Valenzuela, MD, Editor-in-Chief
Issue 2 · Reading list
Explore the research
100 readings · Page 3 of 5
- Original article
Headache and migraine · CC BY 4.0
Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial.
Andreas Straube, J Ellrich, O Eren, B Blum et al.
The journal of headache and pain · 2015
- Original article
Headache and migraine · CC BY 4.0
IL-17 crosses the blood-brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine.
Hao Chen, Xueqian Tang, Jin Li, Bangyan Hu et al.
The journal of headache and pain · 2022
- Original article
Headache and migraine · CC BY 4.0
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design.
Daniel Serrano, Richard B Lipton, Ann I Scher, Michael L Reed et al.
The journal of headache and pain · 2017
- Original article
Headache and migraine · CC BY 4.0
MicroRNA-155-5p promotes neuroinflammation and central sensitization via inhibiting SIRT1 in a nitroglycerin-induced chronic migraine mouse model.
Qianwen Wen, Yunfeng Wang, Qi Pan, Ruimin Tian et al.
Journal of neuroinflammation · 2021
- Original article
Headache and migraine · CC BY 4.0
A prospective real-world analysis of erenumab in refractory chronic migraine.
Giorgio Lambru, Bethany Hill, Madeleine Murphy, Ivona Tylova et al.
The journal of headache and pain · 2020
- Original article
Headache and migraine · CC BY 4.0
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.
Andrew M Blumenfeld, Richard J Stark, Marshall C Freeman, Amelia Orejudos et al.
The journal of headache and pain · 2018
- Original article
Headache and migraine · CC BY 4.0
Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine.
Regina Rendas-Baum, Min Yang, Sepideh F Varon, Lisa M Bloudek et al.
Health and quality of life outcomes · 2014
- Original article
Headache and migraine · CC BY 4.0
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa et al.
The journal of headache and pain · 2021
- Original article
Headache and migraine · CC BY 4.0
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study.
Piero Barbanti, Licia Grazzi, Gabriella Egeo, Anna Maria Padovan et al.
The journal of headache and pain · 2015
- Original article
Headache and migraine · CC BY 4.0
Current and emerging evidence-based treatment options in chronic migraine: a narrative review.
Elio Clemente Agostoni, Piero Barbanti, Paolo Calabresi, Bruno Colombo et al.
The journal of headache and pain · 2019
- Original article
Headache and migraine · CC BY 4.0
P2Y12 receptor mediates microglial activation via RhoA/ROCK pathway in the trigeminal nucleus caudalis in a mouse model of chronic migraine.
Feng Jing, Yixin Zhang, Ting Long, Wei He et al.
Journal of neuroinflammation · 2019
- Original article
Headache and migraine · CC BY 4.0
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation.
Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos Mitsikostas et al.
The journal of headache and pain · 2018
- Original article
Headache and migraine · CC BY 4.0
Increased connectivity of pain matrix in chronic migraine: a resting-state functional MRI study.
Mi Ji Lee, Bo-Yong Park, Soohyun Cho, Sung Tae Kim et al.
The journal of headache and pain · 2019
- Original article
Headache and migraine · CC BY 4.0
P2X7R-mediated autophagic impairment contributes to central sensitization in a chronic migraine model with recurrent nitroglycerin stimulation in mice.
Li Jiang, Yixin Zhang, Feng Jing, Ting Long et al.
Journal of neuroinflammation · 2021
- Original article
Headache and migraine · CC BY 4.0
Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation.
Dimos D Mitsikostas, Lars Edvinsson, Rigmor H Jensen, Zaza Katsarava et al.
The journal of headache and pain · 2014
- Original article
Headache and migraine · CC BY 4.0
Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.
Modar Khalil, Hassan W Zafar, Victoria Quarshie, Fayyaz Ahmed
The journal of headache and pain · 2014
- Original article
Headache and migraine · CC BY 4.0
Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model.
Ting Long, Wei He, Qi Pan, Shanshan Zhang et al.
The journal of headache and pain · 2020
- Original article
Headache and migraine · CC BY 4.0
Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives.
Tiffani J Mungoven, Luke A Henderson, Noemi Meylakh
Frontiers in pain research (Lausanne, Switzerland) · 2021
- Original article
Headache and migraine · CC BY 4.0
The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.
Stephen D Silberstein, Joshua M Cohen, Michael J Seminerio, Ronghua Yang et al.
The journal of headache and pain · 2020
- Original article
Headache and migraine · CC BY 4.0
Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience.
Antonio Russo, Marcello Silvestro, Fabrizio Scotto di Clemente, Francesca Trojsi et al.
The journal of headache and pain · 2020
